版本:
中国

BRIEF-Incyte and Merck provide additional details on previously announced collaboration

March 31 Incyte Corp-

* Incyte and Merck provide additional details on previously announced collaboration investigating epacadostat and Keytruda® (pembrolizumab)

* Says expanded collaboration now includes seven pivotal studies

* Says clinical program on epacadostat and keytruda now include seven registrational trials across five tumor types Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐